BRTX vs PKI
BioRestorative Therapies Inc (BRTX) versus PKI (PKI) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
PKI (PKI) common stock.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
PKI does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M.
Not investment advice. Open the BRTX and PKI stock pages for the full models.
Not investment advice.